NOVAVAX BOND HOLDERS ELECT TO CONVERT $6 MILLION OF OUTSTANDING NOTES

Novavax, Inc. (Nasdaq: NVAX) announced today that certain holders of $6.0 million face amount of the company's 4.75% senior convertible notes due July 15, 2009 (the "Notes") exercised their optional conversion right to convert such Notes into 1,056,338 shares of Novavax Common Stock at the per share conversion price of $5.68. As a result of the conversion, the aggregate principal amount of Notes outstanding will be reduced from $35.0 million to $29.0 million and the company's stockholders' equity will be increased by the same amount.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/10-27-2005/0004197300&EDATE=)